National trends in total hip arthroplasty for traumatic hip fractures: An analysis of a nationwide all-payer database

Table 1 Comparison of comorbidities between patients who underwent hemiarthroplasty and total hip arthroplasty for a femoral neck fracture between 2005 and 2014

	THA (%)	Hemi (%)	P value
AIDS	0.10	0.10	P < 0.05
History of alcohol	3.70	2.60	P < 0.05
History of drug use	1.00	0.50	P < 0.05
CHF	11.00	16.80	P < 0.05
Chronic lung disease	20.30	21.60	P < 0.05
Coagulopathy	6.50	6.40	NS
Depression	12.60	13.00	NS
Diabetes	15.30	17.00	P < 0.05
Hypertension	62.20	69.10	P < 0.05
Hypothyroid	17.10	19.10	P <0.05
Obesity	4.50	2.30	P < 0.05
Renal disease	9.60	13.40	P < 0.05

AIDS: Acquired immunodeficiency syndrome; CHF: Congestive heart failure; NS: Not statistically significant; THA: Total hip arthroplasty.

Table 2 Comparison of demographics between patients who underwent hemiarthroplasty and total hip arthroplasty for a femoral neck fracture between 2005 and 2014

	THA (%)	Hemi (%)	P value
Female	69.60	72.70	P < 0.05
Race
1: White	88.20	88.20	ns
2: Black	4.50	3.90	P < 0.05
3: Hispanic	3.70	4.40	P < 0.05
4: Asian/Pacific Island	1.00	1.40	P < 0.05
5: Native American	0.40	0.40	P < 0.05
6: Other	2.20	1.80	P < 0.05
Hospital type
1: Rural	14.70	16.80	P < 0.05
2: Urban nonteaching	45.90	47.90	P < 0.05
3: Urban teaching	39.30	35.30	P < 0.05
Hospital region
1: Northeast	19.40	19.20	NS
2: Midwest	23.10	23.60	NS
3: South	41.60	38.50	P < 0.05
4: West	15.90	18.70	P < 0.05
Payer type
1: Medicare	74.90	88.50	P < 0.05
2: Medicaid	2.70	1.80	P < 0.05
3: Private	17.30	7.40	P < 0.05
4: Self-pay	2.00	0.80	P < 0.05
5: No charge	0.30	0.10	P < 0.05

NS: Not statistically significant; THA: Total hip arthroplasty.